Long-term safety and efficacy of voclosporin in Asian patients with lupus nephritis: A post hoc analysis of the AURORA 2 trial
Asian patients with active lupus nephritis had sustained proteinuria reductions and a shorter time to proteinuria reduction with voclosporin versus control; voclosporin was well-tolerated.
Authors
- Haruka Matsukawa
- Sandra Navarra (ORCID: https://orcid.org/0000-0003-0094-8654)
- Matt Truman
- Eisuke Nakata
- Tatsuya Atsumi
Institutions
- Otsuka (Japan) (JP)
- University of Santo Tomas Hospital (PH)
- Hokkaido University (JP)
- Services Australia (AU)
- Otsuka Pharmaceutical (Spain) (ES)
- Statistical Service (CY)
- Statistical Research (United States) (US)
Publication Details
- Journal
- Modern Rheumatology
- Published
- 2025-12-17
- DOI
- https://doi.org/10.1093/mr/roaf121
- Primary Topic
- Systemic Lupus Erythematosus Research
- Type
- article
- Field-Weighted Citation Impact
- 0.00